168 related articles for article (PubMed ID: 11435822)
21. [Reassessment of T classification system cutoff value for renal cell carcinoma].
Obara T; Matsuura S; Inoue T; Kumazawa T; Abe A; Horikawa Y; Togashi H; Yuasa T; Tsuchiya N; Satoh S; Sato K; Habuchi T
Nihon Hinyokika Gakkai Zasshi; 2007 Jul; 98(5):671-6. PubMed ID: 17682445
[TBL] [Abstract][Full Text] [Related]
22. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score.
Iimura Y; Saito K; Fujii Y; Kumagai J; Kawakami S; Komai Y; Yonese J; Fukui I; Kihara K
J Urol; 2009 Mar; 181(3):1004-12; discussion 1012. PubMed ID: 19150550
[TBL] [Abstract][Full Text] [Related]
23. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
Blute ML; Amling CL; Bryant SC; Zincke H
Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
[TBL] [Abstract][Full Text] [Related]
24. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
25. Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters.
Delahunt B; Kittelson JM; McCredie MR; Reeve AE; Stewart JH; Bilous AM
Cancer; 2002 Feb; 94(3):658-64. PubMed ID: 11857297
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
27. The critical impact of tumor size in predicting cancer special survival for T3aM0M0 renal cell carcinoma: A proposal of an alternative T3aN0M0 stage.
Li L; Shi L; Zhang J; Fan Y; Li Q
Cancer Med; 2021 Jan; 10(2):605-614. PubMed ID: 33280246
[TBL] [Abstract][Full Text] [Related]
28. [Review of cut-off points between stages T1 and T2 in the 1997 TNM classification of renal carcinoma].
López Luque AJ; Anglada Curado FJ; Carazo Carazo JL; Alvarez Kindelan J; Márquez López J; Leva Vallejo M; Regueiro López JC; Prieto Castro R; Requena Tapia MJ
Actas Urol Esp; 2003 Apr; 27(4):292-6. PubMed ID: 12830551
[TBL] [Abstract][Full Text] [Related]
29. Proposal of an improved prognostic classification for pT3 renal cell carcinoma.
Terrone C; Gontero P; Volpe A; Porpiglia F; Bollito E; Zattoni F; Frea B; Tizzani A; Fontana D; Scarpa RM; Rossetti SR
J Urol; 2008 Jul; 180(1):72-8. PubMed ID: 18485380
[TBL] [Abstract][Full Text] [Related]
30. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
31. Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma.
Brookman-May S; May M; Zigeuner R; Shariat SF; Scherr DS; Chromecki T; Moch H; Wild PJ; Mohamad-Al-Ali B; Cindolo L; Wieland WF; Schips L; De Cobelli O; Rocco B; Santoro L; De Nunzio C; Tubaro A; Coman I; Feciche B; Truss M; Dalpiaz O; Hohenfellner M; Gilfrich C; Wirth MP; Burger M; Pahernik S;
J Urol; 2011 Dec; 186(6):2175-81. PubMed ID: 22014800
[TBL] [Abstract][Full Text] [Related]
32. [Impact of tumor size on long-term survival of patients with organ-confined renal cell cancer].
Merseburger AS; Wegener G; Horstmann M; Oelke M; Zumbrägel A; Bokemeyer C; Kollmannsberger C; Jonas U; Stenzl A; Kuczyk M
Aktuelle Urol; 2003 Dec; 34(7):469-74. PubMed ID: 14655083
[TBL] [Abstract][Full Text] [Related]
33. The influence of clinical and pathological stage discrepancy on cancer specific survival in patients treated for renal cell carcinoma.
Svatek RS; Lotan Y; Herman MP; Duchene DA; Sagalowsky AI; Cadeddu JA
J Urol; 2006 Oct; 176(4 Pt 1):1321-5; discussion 125. PubMed ID: 16952621
[TBL] [Abstract][Full Text] [Related]
34. Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project).
May M; Surcel C; Capitanio U; Dell'Oglio P; Klatte T; Shariat S; Ecke T; Wolff I; Vergho D; Wagener N; Huck N; Pahernik S; Zastrow S; Wirth M; Borgmann H; Haferkamp A; Musquera M; Krabbe LM; Herrmann E; Scavuzzo A; Mirvald C; Hutterer G; Zigeuner R; Stief CG; Waidelich R; Cindolo L; Kalusova K; Brookman-May SD;
Scand J Urol; 2017 Aug; 51(4):269-276. PubMed ID: 28399699
[TBL] [Abstract][Full Text] [Related]
35. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.
Fujii Y; Saito K; Iimura Y; Sakai Y; Koga F; Kawakami S; Kumagai J; Kihara K
J Urol; 2008 Oct; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704
[TBL] [Abstract][Full Text] [Related]
36. Influence of tumor size on oncological outcomes of pathological T3aN0M0 renal cell carcinoma treated by radical nephrectomy.
Chen L; Ma X; Li H; Gu L; Li X; Gao Y; Xie Y; Zhang X
PLoS One; 2017; 12(3):e0173953. PubMed ID: 28288191
[TBL] [Abstract][Full Text] [Related]
37. Prognostic variables to predict cancer-related death in incidental renal tumours.
Bensalah K; Pantuck AJ; Crepel M; Verhoest G; Méjean A; Valéri A; Ficarra V; Pfister C; Ferrière JM; Soulié M; Cindolo L; De La Taille A; Tostain J; Chautard D; Schips L; Zigeuner R; Abbou CC; Lobel B; Salomon L; Lechevallier E; Descotes JL; Guillé F; Colombel M; Belldegrun AS; Patard JJ
BJU Int; 2008 Nov; 102(10):1376-80. PubMed ID: 18727618
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
[TBL] [Abstract][Full Text] [Related]
39. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging.
Hafez KS; Fergany AF; Novick AC
J Urol; 1999 Dec; 162(6):1930-3. PubMed ID: 10569540
[TBL] [Abstract][Full Text] [Related]
40. Accuracy of the revised 2010 TNM classification in predicting the prognosis of patients treated for renal cell cancer in the north east of England.
Veeratterapillay R; Simren R; El-Sherif A; Johnson MI; Soomro N; Heer R
J Clin Pathol; 2012 Apr; 65(4):367-71. PubMed ID: 22287690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
